India, July 31 -- The Global Drug Regulatory Conclave (GDRC) 2026, organised by Pharmexcil, focused on strengthening India's pharmaceutical regulatory ecosystem. India is building a future-ready drug regulatory framework to accelerate healthcare innovation while maintaining the highest standards of patient safety, quality, and efficacy, Union Minister for Health and Family Welfare J.P. Nadda said in his virtual address at the inaugural Global Drug Regulatory Conclave (GDRC) 2026, on 30 July in Delhi.

Reinforcing this vision, Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi announced at the event that the Central Drugs Standard Control Organisation (CDSCO) will roll out the first phase of an end-to-end digital drug reg...